FUNDAMENTALS · Fundamentals · US Consumer Defensive

The Clorox (CLX) Fundamentals 2026 — P/E 15.5x, Revenue Analysis | SniperIQ

The Clorox (CLX) is a US-listed Consumer Defensive company in Household & Personal Products with a market capitalization of

1.6B, trading at $96.09 on the NYSE. This SniperIQ fundamentals page covers The Clorox's valuation (P/E 15.5x), profitability (net margin 11.2%), revenue ($7.1B in FY2025), balance-sheet quality, and AI signal context — from live market data, research only.

Market Cap
1.6B
P/E (TTM)15.5x
Net Margin11.2%
Revenue (FY25)$7.1B

Full research coverage

  • 8-Quarter Revenue & Margin Trend
  • Debt Maturity & Coverage
  • Peer Valuation Comparison
  • Free Cash Flow & Owner Earnings
  • AI Signal + Institutional Flow
  • DCF Valuation Model

Frequently Asked Questions

What is The Clorox's market cap?

The Clorox (CLX) has a market capitalization of approximately

1.6B, trading at $96.09 on the NYSE. Market cap moves with the live share price.

What is The Clorox's P/E ratio?

The Clorox's trailing twelve-month P/E ratio is 15.5x. Valuation multiples are best compared with Consumer Defensive sector peers rather than read in isolation.

How profitable is The Clorox?

The Clorox runs a net profit margin of 11.2%, a gross margin of 43.8%, and an operating margin of 15.7%. Margins and ROE indicate how efficiently the business converts sales into profit and shareholder returns.

How much revenue does The Clorox generate?

The Clorox reported revenue of $7.1B for fiscal year 2025, with net income of $810M and earnings per share (EPS) of 6.56. SniperIQ tracks the full 8-quarter revenue and margin trend on the research dashboard.

Does The Clorox pay a dividend?

The Clorox offers a trailing dividend yield of about 5.2%. Dividend sustainability depends on payout ratio, free cash flow, and earnings stability — all tracked in SniperIQ's fundamentals view.

Is The Clorox financially healthy?

The Clorox carries a debt-to-equity ratio of -66.96x and a current ratio of 0.84x, with a market beta of 0.53. Lower leverage and a current ratio above 1.0 generally signal a stronger balance sheet.

Is The Clorox a good stock to buy in 2026?

SniperIQ provides research-only market intelligence, not personalised financial advice or a buy/sell call. For The Clorox (CLX) the key facts are: market cap

1.6B, P/E 15.5x, revenue $7.1B, 52-week range 84.7-132.03. Weigh valuation, profitability, growth, and balance-sheet strength against Consumer Defensive peers and form your own view.

Track The Clorox's full fundamentals live

Get The Clorox's 8-quarter revenue and margin trend, peer comparison, DCF model, and AI signal on the SniperIQ research dashboard.

Related: BJ's Wholesale Club Holdings (BJ) fundamentals · Tenmaya Store (9846) fundamentals · Shanghai Jahwa United (600315) fundamentals · Ahjikan (2907) fundamentals · All stock fundamentals · AI signal library
Research Hubs: Fundamentals library · Screeners · Institutional positioning · Super investors · Daily signals · Platform comparisons